Susan Hasty, Publisher
Table of Contents . . . February 10th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Cancer Gene Therapy - CT Scans Used to Evaluated Lung Cancer Responses to Therapy
Allograft Survival - Engineered Dendritic Cells Induce Hyporesponsiveness
Antisense Technology - ISIS 5132 Specifically Reduces Target Gene Expression
Antisense Technology - Modified Bases Enhance Specificity of Base Pairing
Cancer Gene Therapy - p21 Gene Transfer Induced Apoptosis in Esophageal Cancer Cells
Diagnostics - Protocol Effective Without Fluorescent Primers, Automatic Instrumentation
Somatic Gene Therapy - Forced MyHCIIB Expression Follows Genetic Manipulation
Suicide Gene Therapy - Cytosine Deaminase/5-Fluorocytosine-Based Vaccination Studied
Vaccine Development (TB) - Enhanced Production of Recombinant Antigens Possible
Vector Development - Inclusion of SV40 Sequence Improves Nonviral Gene Delivery
Anti-Angiogenesis - Antisense Strategies May Effectively Treat Tumors
Cancer Gene Therapy - B7.1 Gene Transfer Improves T-Cell Activation
Cancer Gene Therapy - Redirected Measles Virus Hemagglutinin Protein Attacks Cancer Cells
HIV Vaccine - DNA Vaccine Induced Mucosal and Systemic Immune Response
Hemophilia B (Gene Therapy) - Expression of Therapeutic Transgene Shown in Rodent Study
Osteoporosis - Enzyme a New Target for Therapeutic Drug Development
Tumor Suppression - Anti-Cancer Agents Work Via Anti-Angiogenic Mechanism
Atherosclerosis - Gene Therapy May Help Bypass Repeat Heart Surgeries
Cancer Gene Therapy - Rb2 Therapy Shrinks Tumors in Mice
Cancer Gene Therapy - TIMP-2 Gene Transfer Prevents Liver Metastases
DNA Vaccines (Development) - Collaborative Study Using INJEX Needle-Free Injection System Announced
Vaccines (Patents) - Patent on Dry Powder DNA Formulations Announced
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.